Biotech goes Hollywood

A few years ago, the biotech venture world in LA was almost ‘nonexistent’ — now Joseph Panetta, CEO of Biocom California, says the region is undergoing a major change.

By Taren Grom • April 13, 2022

'Bootcamp' helps rare disease advocates learn the ropes of drug development

Ultragenyx’s CEO on why supporting others in rare diseases pays dividends all around.

By Kim Ribbink • April 12, 2022

Explore the Trendline➔

Artificial intelligence & machine learning

After years of excited buzz around the potential of artificial intelligence and machine learning, pharma has begun to realize the true implications and potential value of these technologies.

By PharmaVoice staff

Why the war in Ukraine could accelerate the deglobalization of clinical trials

COVID-19 slowed many studies — but the war could further strain clinical trials worldwide.

By Michael Gibney • April 12, 2022

How Congress could play a role in personalized medicine

PGx — a tool to help determine proper dosing — may be poised to achieve broader use in healthcare and pharma.

By Kelly Bilodeau • April 11, 2022

Optinose CEO senses big opportunities for the company's nasal delivery device

Peter Miller explains how a repackaged sinus drug has won late-stage clinical success.

By Jared Whitlock • April 11, 2022

Woman of the Week: Lyell Immunopharma's Liz Homans

The CEO has the company poised to capitalize on its moment to address T cell exhaustion.

By Taren Grom • April 6, 2022

A planned trial revives a glimmer of hope for a Huntington's disease treatment

Roche brought a Huntington’s drug back to life after a jarring trial halt.

By Kelly Bilodeau • April 6, 2022

Seeing yourself at the top: Alnylam CEO on why representation matters

Dr. Yvonne Greenstreet became just the sixth woman in the world to head up a biopharma company with a market cap of more than $5 billion when she took on the role of CEO in January.

By Alexandra Pecci • April 6, 2022

An analyst turned pharma CEO learns the art of operations

Under Apurva Saraf’s guidance, Cosette Pharmaceuticals is pivoting wholeheartedly into the cardio space.

By Jared Whitlock • April 5, 2022

Clinical trial recruitment hits the local pharmacy counter

CVS Health's partnership with clinical trial software company Medable is designed to make recruitment easier for patients and drug makers alike.

By Kelly Bilodeau • April 5, 2022

Down but not out: How AVEO's CEO steered the company past an FDA rejection

Michael Bailey explains why focusing on the patient helped AVEO clear regulatory hurdles to bring a new cancer drug across the finish line.

By Kim Ribbink • April 5, 2022

Lessons from improv: Shankar Narayanan’s ‘yes, and’ approach to healthcare leadership

Real Chemistry's CEO is bringing a unique set of skills to the role as he sets off on a company-wide listening tour.

By Taren Grom • April 4, 2022

Time-saving tech lights Alcon's path into digital innovation

Kevin Yapp, global head or omni-channel transformation at the Swiss eye health company shares why the customer should be a  North Star when developing digital tools.

By Kim Ribbink • April 4, 2022

From media to menopause: Creating new spaces in women's telehealth

Why the former editor-in-chief of Marie Claire abandoned her magazine career to create a menopause-focused women's health startup.

By Alexandra Pecci • March 29, 2022

How a rock 'n' roll guru is putting a new spin on health education for patients

A former agent for The Rolling Stones has launched a healthcare streaming platform with a cast of entertainment heavyweights — and he wants pharma to be a headline act.

By Meagan Parrish • March 28, 2022

Rare Patient Voice's president is striving to create a five-star experience for patients

Successful clinical trial recruitment depends on listening to and empowering patients.

By Kim Ribbink • March 23, 2022

Woman of the Week: Merck's Dr. Mary-Ann Etiebet

The associate VP of health equity is on a quest to address the relationship between health, gender and economic opportunities.

By Taren Grom • March 23, 2022

Another pandemic threat looms, and the antibacterial drug pipeline still isn't keeping up

A recent report from BIO details challenges in the antibiotic market — and new policy measures that could help.

By Kelly Bilodeau • March 23, 2022

Why Astellas is adopting a 'focus area approach' to partnerships

Chief Strategy Officer, Naoki Okamura, explains why new trends and innovations require a different approach to alliances.

By Kim Ribbink • March 22, 2022

Psychedelics without the party: Inside MindMed's LSD makeover

MindMed’s CEO, Robert Barrow, on the company’s latest moves to ‘change the world’ with psychedelics.

By Alexandra Pecci • March 21, 2022

BioMarin’s new global head of advocacy is tackling the holy grail of patient engagement

In her new role, Dr. Roz is keeping her patient-first approach.

By Taren Grom • March 21, 2022

Virpax's CEO on leveraging new formulations to move drugs toward approval

Anthony Mack shares his lessons from getting unconventional pharma products across the finish line.

By Meagan Parrish • March 18, 2022

Civica Rx thinks it has a cure for high insulin prices

Civica’s president and CEO, Martin VanTrieste, explains the nonprofit’s aim to manufacture low-cost insulin — and which area of pharma it plans to target next.

By Kelly Bilodeau • March 16, 2022

How Novartis kept its supply chain intact during COVID-19

In an agile pivot, Amit Nastik led Novartis’ manufacturing operations through the pandemic without losing supply chain reliability. 

By Taren Grom • March 16, 2022

Woman of the Week: Ceek Women's Health CEO Fahti Khosrowshahi

Fahti Khosrowshahi, CEO and founder, Ceek Women’s Health, is designing award-winning products to change the face of women's health. 

By Taren Grom • March 16, 2022